Kefir: A Synbiotic with Approved Anticarcinogenic Properties

Author(s): Wissam Zam*, Sally Shahoud, Mansour Hayek, Alaa Saad

Journal Name: Current Bioactive Compounds

Volume 17 , Issue 8 , 2021


Article ID: e010621189545
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: According to WHO report, cancer is the second leading cause of death globally, and approximately 70% of deaths from cancer occur in low- and middle-income countries. From this point, more attention has been given to the role of nutrition in the prevention of cancer development.

Methods: A structured search of bibliographic databases for peer-reviewed research literature dealing with the role of kefir in cancer prevention and treatment was undertaken.

Results: Probiotics are one of the most important food fortifications which are proved to have anticarcinogenic properties. Probiotics can directly bind to carcinogens and alter the production of enzymes by modifying the intestinal environment. Kefir, originating from the Balkan–Caucasian region, is a synbiotic composed of a wide number microflora and exopolysaccharides with approved in vitro and in vivo biological activities. Kefir plays a great potential role in cancer prevention and treatment, interfering with apoptosis, proliferation and transformation.

Conclusion: This review highlights the important role of probiotics, exopolysaccharides and common kefir in preventing different types of cancer, including colon cancer, sarcoma, breast cancer, lung cancer, leukemia, gastric cancer and melanoma.

Keywords: Cancer, kefir, probiotics, exopolysaccharides, apoptosis, proliferation.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 8
Year: 2021
Published on: 28 December, 2020
Article ID: e010621189545
Pages: 9
DOI: 10.2174/1573407216999201228191806
Price: $65

Article Metrics

PDF: 99